quote.fool.comToday's FeaturesQuotes, News, Charts, Data

site search


• Hot Archives
• Log-In
• Message Boards
• Register
• Favorites
• Boards Help
• Polling all Fools
Read Foolish Books
Foolish Books
Today's Features
Everything we've written today and this week.
Become a Fool!
Why not get the many benefits of being a registered Fool? Register -- it's fast, easy, and free.

Hot Topics

Check out these message board conversations, and join in the discussion! But first, please read our disclaimer.

Intel From the Inside
Intel is often called a gorilla, but a former employee says this company "stomps like an elephant, runs like a cheetah." Get a rare insider's view of life at a company described as a complete machine that can turn on a dime.

Internet for Dummies
AOL is simple, but cable is fast. As 'Netizens gain experience, some wonder if they'll dump the training wheels of America Online for @Home.

Will Competition Hurt eBay's Margins?
Fools debate this all-important issue as more auction sites come online.

Learning Lasers
Uniphase followers continue the educational process towards understanding this emerging technology. Someday, will we all communicate this way?

DoubleClick's Earnings Call
Can an Internet company merely meet estimates without getting punished? DCLK Fools look beyond the numbers and examine the whole picture. What a Foolish idea.

Digital Downloading
The Amazon.com board envisions the future when popular reading material is digitized and consumers simply download it to a "hand-friendly" digital book. But will the technology ever put booksellers out of business?

Intel and EMC
Fools on the EMC board explore potential competition or alliances with Intel as the chipmaker unfolds its plans to build data service centers. Perhaps these two companies can benefit each other.

The New Wal-Mart
A Fool questions whether Wal-Mart's lofty P/E ratio is sustainable for this giant retailer. But a former Wal-Mart staffer says the company is leaner and meaner than in Mr. Sam's day.

Figuring Out Pfizer
Faithful Pfizer Fools continue digging into the fundamentals of the pharmaceutical giant to discover its long-term prospects.



  home  | news  | specials  | strategies  | personal finance  | school  | help  

© Copyright 1995-2000, The Motley Fool. All rights reserved. This material is for personal use only. Republication and redissemination, including posting to news groups, is expressly prohibited without the prior written consent of The Motley Fool. The Motley Fool is a registered trademark and the "Fool" logo is a trademark of The Motley Fool, Inc. Contact Us